Powered by

FDA OKs clinical trial of COVID-19 survivor plasma

Apr 05, 2020 - Milwaukee Journal Sentinel (Wisconsin)

Federal regulators on Friday approved a clinical trial at Johns Hopkins University to test the use of plasma from recovered COVID-19 patients to treat doctors, nurses and other first responders who are at high risk of exposure to the new virus.

The news follows a nationwide effort by more than 100 researchers and at least 40 large hospitals to get clinical trials started using survivor plasma, a technique that has been used for more than a century to quell outbreaks of polio, measles, mump...